![Amy Burroughs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Amy L.
Burroughs is currently an Independent Director at Tenaya Therapeutics, Inc. since 2022.
Former roles include President, Chief Executive Officer & Director at Cleave Therapeutics, Inc. from 2019 to 2023; Chief Executive Officer & Director at Terns Pharmaceuticals, Inc. from 2025 to 2026; Independent Director at DiaMedica Therapeutics, Inc. from 2021 to 2023; Commercial Team Leader at Genentech, Inc.; Principal at Procter & Gamble Co.; Chief Commercial Officer & Head-Business Development at APT Pharmaceuticals, Inc. in 2009; and Principal at WholeHealth Living, Inc. and ePhysician, Inc. Education includes undergraduate studies at Dartmouth College and an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/12/2022 |
| Società | Posizione | Fine |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Amministratore Delegato | 05/05/2026 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Amministratore Delegato | 01/10/2023 |
| DIAMEDICA THERAPEUTICS INC. | Direttore/Membro del Consiglio | 01/03/2023 |
ePhysician, Inc.
 ePhysician, Inc. Packaged SoftwareTechnology Services Develops point-of-care software products that enable transferring of patient information via the Internet | Corporate Officer/Principal | - |
WholeHealth Living, Inc.
 WholeHealth Living, Inc. Medical/Nursing ServicesHealth Services Operates outpatient healthcare facilities | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WholeHealth Living, Inc.
WholeHealth Living, Inc. Medical/Nursing ServicesHealth Services Operates outpatient healthcare facilities | Health Services |
ePhysician, Inc.
ePhysician, Inc. Packaged SoftwareTechnology Services Develops point-of-care software products that enable transferring of patient information via the Internet | Technology Services |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
